Intra-Cellular Therapies, Inc. reports

Company location: Bedminster, NJ
Fiscal year end: 31 December

Intra-Cellular Therapies, Inc. has filed 1,007 SEC EDGAR filings since 08 Feb 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page

Current page

4

Filing date: 05 Mar 2024
Reporting date: 01 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 28 Feb 2024
Reporting date: 27 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 27 Feb 2024
Reporting date: 23 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 27 Feb 2024
Reporting date: 23 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 27 Feb 2024
Reporting date: 23 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 27 Feb 2024
Reporting date: 23 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 27 Feb 2024
Reporting date: 23 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 27 Feb 2024
Reporting date: 26 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 27 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144/A File 001-36274

144/A filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 26 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-36274

10-K

Filing date: 22 Feb 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36274

8-K

Filing date: 22 Feb 2024
Reporting date: 22 Feb 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-87380

SCHEDULE 13G/A

Filing date: 13 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87380

SC 13G/A filing

Filing date: 09 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87380

SC 13G/A filing

Filing date: 09 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87380

SEC SCHEDULE 13G

Filing date: 08 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 05 Feb 2024
Reporting date: 01 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 05 Feb 2024
Reporting date: 01 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 05 Feb 2024
Reporting date: 01 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing